Archives
-
Dimetridazole: Research Context and Evidence Review
2026-10-04
A source-grounded overview of Dimetridazole (1,2-Dimethyl-5-nitroimidazole), emphasizing residue analysis, conceptual antimicrobial research, published sensor findings, evidence strength, and important limitations.
-
Aedes aegypti Xenobiotic Transport Findings
2026-10-03
Kennel and Rouhier examined how three structurally distinct xenobiotics influenced excretion, mortality, and candidate organic cation transporter transcripts in female Aedes aegypti. The study’s main contribution is to separate physiological clearance effects from measured transporter-expression responses, showing that chemical structure strongly shaped excreted material and mortality while producing limited changes in the assessed transcripts.
-
CRISPR/Cas9 Knock-In Raises Rabbit Pharming Yield
2026-10-02
Song et al. developed a rabbit line in which a tdTomato reporter was integrated under the native CSN2 β-casein promoter using CRISPR/Cas9-mediated knock-in and HDR enhancement with RS-1. Homozygous animals produced 15–20 g/L of recombinant reporter protein in milk, illustrating how locus-directed integration and breeding can address the variability of conventional transgenic pharming.
-
Aurora A, SAM Metabolism, and Trained Immunity
2026-10-01
Li et al. identify Aurora kinase A as a metabolic-epigenetic regulator of β-glucan-trained immunity, linking kinase activity to the mTOR–FOXO3–GNMT axis and endogenous S-adenosylmethionine availability. Their multi-omics and in vivo data show how SAM-dependent histone methylation supports inflammatory gene priming and the antitumor activity of trained macrophages.
-
Tubastatin A for Reliable Cell Assays
2026-10-01
Learn how Tubastatin A (SKU A4101) can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity workflows through selective HDAC6 inhibition. This scenario-based guide connects practical assay design with biochemical potency, solvent handling, and emerging translational evidence.
-
6-OHDA Hydrochloride: Mechanism and Workflow
2026-09-30
6-OHDA hydrochloride is a catecholaminergic neurotoxin used to create experimental neuronal lesion models. Its transporter-dependent uptake and oxidative injury mechanism is distinct from the 25-hydroxycholesterol pathway described in tumor-associated macrophages.
-
Itraconazole: Mechanism and Candida Biofilm Research
2026-09-30
Itraconazole is a triazole antifungal agent with reported activity against Candida species and documented CYP3A4 interaction utility. Its product-reported benchmarks support solvent planning, while recent Candida albicans biofilm research shows that PP2A-driven autophagy can alter antifungal resistance without directly validating itraconazole treatment.
-
Dyngo-4a: Mapping Dynamin-Dependent LNP Uptake
2026-09-29
Dyngo-4a provides a practical perturbation tool for testing whether dynamin-dependent membrane trafficking contributes to lipid nanoparticle delivery, rather than merely measuring final mRNA expression. This workflow extends serial human T-cell engineering studies with matched uptake, expression, and viability readouts while clearly separating established evidence from proposed mechanistic experiments.
-
HyperScribe Co-transcription mRNA Synthesis Kit Plus
2026-09-29
Build translation-ready, ARCA-capped transcripts with a template-encoded poly(A) tail for in vitro translation, RNA vaccine development, and RNA interference studies. This workflow-focused guide connects reliable mRNA synthesis with practical assay design, quality control, and nanovaccine research limitations.
-
Necrostatin-1: From RIP1 Biology to Translation
2026-09-28
A translational framework for using Necrostatin-1 as a RIP1 kinase inhibitor to connect necroptosis, inflammatory signaling, and tissue-injury models.
-
From RNA Nanocarriers to Translational Readouts
2026-09-28
A new potato virus X-based platform illustrates how programmable protein–RNA assemblies could expand nucleic acid delivery research. Translational teams can pair this kind of platform innovation with carefully designed qPCR workflows—while recognizing that nucleic acid detection is not, by itself, evidence of functional delivery.
-
AZD0156 and the Metabolic Logic of ATM Inhibition
2026-09-27
Explore how AZD0156, an ATM kinase inhibitor, can help investigate the intersection of DNA repair and tumor metabolism. Using high-grade serous ovarian cancer findings, this article explains how to distinguish a true combination effect from a simple loss of viability.
-
DiscoveryProbe™ Immunology/Inflammation Library
2026-09-26
Explore how the DiscoveryProbe Immunology/Inflammation Compound Library can support rigorous immunomodulator screening. This article focuses on turning multiplex immune-cell phenotypes into stronger, better-controlled inflammation target validation.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-25
This study introduces patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell populations, bringing key features of the tumor microenvironment into an in vitro model. The authors show that stromal inclusion can reshape gene expression and drug sensitivity, supporting more context-aware preclinical testing while leaving clinical predictive value to be established.
-
Doxorubicin Workflows for Cancer and Cardiac Screens
2026-09-25
Use Doxorubicin as a mechanism-informed reference for cancer-cell response assays and as a carefully interpreted perturbagen in iPSC-cardiomyocyte toxicity screens. This workflow connects dose and exposure design with high-content imaging, deep-learning phenotyping, and practical troubleshooting—without treating a cardiac signal as a measure of anticancer efficacy.